BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President
January 09, 2024 08:30 ET
|
BioCorRx Inc
ANAHEIM, CA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and...
BioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder
July 18, 2023 08:30 ET
|
BioCorRx Inc
ANAHEIM, CA, July 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and...
Drug Testing Market Size to Cross USD 15.7 Bn by 2033 with CAGR of 5.3% | Transparency Market Research
March 20, 2023 11:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, March 20, 2023 (GLOBE NEWSWIRE) -- According to the latest research by Transparency Market Research, the drug testing market was estimated to attain a global...
BioCorRx Attended 4th Annual NIH HEAL Initiative Investigator Meeting; Shares Update on BICX104 Data
February 23, 2023 08:30 ET
|
BioCorRx Inc
ANAHEIM, CA, Feb. 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance use and related...
Turning Point of Tampa Opens Drug and Alcohol Detoxification Program
August 12, 2022 09:00 ET
|
Turning Point of Tampa
Tampa, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Turning Point of Tampa, a leading treatment provider in Tampa, Florida is pleased to announce the expansion of services to include medical detoxification...
X Waiver Mini-Course Expands Emergency Clinician Recognition and Treatment of Opioid Withdrawal, Study Finds
April 13, 2022 08:00 ET
|
American College of Medical Toxicology
Phoenix, AZ, April 13, 2022 (GLOBE NEWSWIRE) -- “A Brief Educational Intervention to Increase ED Initiation of Buprenorphine for Opioid Use Disorder (OUD)” was a study funded by a grant to the...
American College of Medical Toxicology Presents 2022 Virtual Annual Scientific Meeting & Symposium
January 25, 2022 09:55 ET
|
American College of Medical Toxicology
Phoenix, AZ, Jan. 25, 2022 (GLOBE NEWSWIRE) -- The American College of Medical Toxicology (ACMT) 2022 Annual Scientific Meeting (ASM) will be held virtually from Friday, March 11 through Sunday,...
Illicit Benzodiazepine Overdose Trends Detected by Toxicology Investigators Consortium (ToxIC)
September 02, 2021 11:49 ET
|
American College of Medical Toxicology
Phoenix, AZ, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Data gathered by ToxIC’s Fentanyl Analog Study was reported in the CDC’s August 27, 2021 Morbidity and Mortality Weekly Report (MMWR) “Notes from the...
Meeting the Moment, Reflections One Year On: The American College of Medical Toxicology’s Response to the COVID-19 Pandemic
March 25, 2021 10:00 ET
|
American College of Medical Toxicology
Phoenix, AZ, March 25, 2021 (GLOBE NEWSWIRE) -- March 2021 marks the one-year anniversary of the World Health Organization’s official designation of the outbreak of the COVID-19 pandemic. The...
BioCorRx Announces Award of $2.8 Million, the Second Tranche of a NIDA Grant for the Development of BICX102, a Sustained Release Naltrexone Implant for the Treatment of Opioid Use Disorder
January 30, 2020 09:31 ET
|
BioCorRx Inc
ANAHEIM, CA, Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...